Dr. Laura Esserman on Breast Cancer Risk Assessments and The WISDOM Study (KPIX March 2024)

WISDOM Forum: Breast Cancer in Younger WomenПодробнее

The Future of Breast Cancer Screening and Detection - The WISDOM StudyПодробнее

Cancer Data: Improve Screening and Breast Cancer Awareness with Dr. Laura EssermanПодробнее

Breast Cancer OverdiagnosisПодробнее

American Cancer Society and WISDOMПодробнее

Breast Cancer Screening and Wisdom TrialПодробнее

Dr. Esserman on Personalized Screenings for Breast CancerПодробнее

Bringing "WISDOM" to Breast Cancer ScreeningПодробнее

The Wisdom Study Takes A New Look At Breast Cancer ScreeningsПодробнее

Breast Health During COVID-19 with Laura EssermanПодробнее

Iconoclastic Breast Surgeon Laura Esserman Challenges the Status QuoПодробнее

2022 Breast Cancer Personalized Risk Assessment, Education and Prevention (B-PREP) Patient ForumПодробнее

Breast Cancer Risk Assessment - A Personalized Approach to Breast HealthПодробнее

Breast Cancer Risk Assessment & Prevention Video - Brigham and Women's HospitalПодробнее

Dr. Esserman on the Basis for the I-SPY 2 Trial in Breast CancerПодробнее

ELEANOR interim analysis: real-world study of adjuvant neratinib in HER2+/HR+ early breast cancerПодробнее